Stockreport

LENSAR Reports First Quarter 2024 Results and Provides Business Update

LENSAR, Inc.  (LNSR) 
PDF Total Revenue increased 28% and Procedure volume increased 25% over the first quarter of 2023Increased ALLY® Adaptive Cataract Treatment System installed base to 65 syst [Read more]